A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147
Clinical trial NCT05955872 · COMPLETED
Trial details
- NCT number
- NCT05955872
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-19
- Primary completion
- 2023-09-02
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.